WebMar 9, 2024 · Managing Director, Investor Relations Corporate Communications [email protected] 646-876-5521 For Guardant Investor Contact: Alex Kleban [email protected] +1... WebHead-Investor Relations, Guardant Health, Inc. Currently, Carrie Mendivil occupies the position of Head-Investor Relations at Guardant Health, Inc., Director-Investor …
Guardant Health Reports Third Quarter 2024 Financial Results
WebGuardant Health, Inc. (the “Company”)’sfuture results and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. WebPALO ALTO, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of … mukilteo weather today
Guardant Health Reports Second Quarter 2024 Financial Results
WebInvestor Relations Contact Info. Address. News Corp 1211 Avenue of the Americas New York, NY 10036. Investor Relations Contact. Michael Florin SVP, Head of Investor Relations 212-416-3048 [email protected]. Back to Investor Relations. News Corp. About Us; Businesses & Brands; Leadership; Careers; Investor Relations; WebKey publications In collaboration with researchers and thought leaders around the world, Guardant Health uses scientific expertise and cutting-edge innovation to help drive precision oncology forward. Below are key publications. Key Publications by Topic: Cancer Screening Early-Stage Cancer Minimal Residual Disease Detection WebFeb 16, 2024 · Investors & Media. Ultragenyx is a biopharmaceutical company committed to bringing to patients novel products for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear … how to make your yt channel public